CAR-T cell expansion platforms yield distinct T cell differentiation states-Reference-Cited by-同舟云学术

CAR-T cell expansion platforms yield distinct T cell differentiation states

Published:2024-07 Issue:7 Volume:26 Page:757-768
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Song Hannah W.^ORCID,Prochazkova Michaela,Shao Lipei^ORCID,Traynor Roshini,Underwood Sarah,Black Mary,Fellowes Vicki^ORCID,Shi Rongye,Pouzolles Marie,Chou Hsien-Chao,Cheuk Adam T.,Taylor Naomi,Jin Ping,Somerville Robert P.,Stroncek David F.,Khan Javed,Highfill Steven L.

Funder

Clinical Center

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Reference48 articles.

1. Synapse-tuned CARs enhance immune cell anti-tumor activity;Chockley;Nat Biotechnol,2023

2. Armored CAR T-cells: the next chapter in T-cell cancer immunotherapy;Hawkins;Biologics,2021

3. Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells;Mai;Proc Natl Acad Sci U S A,2023

4. Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness;Lau;Cytotherapy,2023

5. Scalable manufacturing of CAR T cells for cancer immunotherapy;Abou-El-Enein;Blood Cancer Discov,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for Improving CAR T Cell Persistence in Solid Tumors;Cancers;2024-08-16

2. The next frontier in immunotherapy: potential and challenges of CAR-macrophages;Experimental Hematology & Oncology;2024-08-05

3. Ex vivo T cell differentiation in adoptive immunotherapy manufacturing: Critical process parameters and analytical technologies;Biotechnology Advances;2024-08

4. A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells;Nature Biomedical Engineering;2024-06-04

5. Proteomics of human platelet lysates and insight from animal studies on platelet protein diffusion to hippocampus upon intranasal administration;APL Bioengineering;2024-05-06